SS Innovations hits 5k surgeries with Mantra robots across 7 countries

Rhea-AI Filing Summary

SS Innovations International, Inc. (Nasdaq: SSII) filed a Form 8-K dated 15 July 2025 to disclose an operational milestone. The company reports that it has now installed more than 100 SSi Mantra surgical robotic systems across India and six other countries. Collectively, the installed base has facilitated over 5,000 surgical procedures, including 240 cardiac surgeries and 32 telesurgeries.

The filing contains no revenue, earnings, guidance or transactional information; it simply furnishes the related press release as Exhibit 99.1. While financial details are absent, the figures provided highlight growing clinical adoption and an expanding geographic presence for the Mantra platform.

Positive

• More than 100 Mantra systems installed, indicating meaningful market penetration.
• Over 5,000 surgical procedures completed, evidencing real-world utilization and reliability.
• Adoption spans seven countries, suggesting growing international footprint.
• Use cases include 240 cardiac surgeries and 32 telesurgeries, underscoring platform versatility.

Negative

• No financial metrics (revenue, ASP, margins) were provided, limiting assessment of economic impact.

Insights

Financial Analyst

TL;DR: Installation milestone confirms product traction; no financial data disclosed, but adoption trend looks favorable.

The 8-K is limited to an Other Events disclosure, yet the numbers are noteworthy for investors tracking commercialization progress. Surpassing 100 system installations and 5,000 cumulative procedures demonstrates clinical acceptance and operational scalability for the Mantra robotic platform. Cardiac and telesurgery use cases broaden its perceived versatility. Absence of revenue figures, ASPs or margin data prevents direct valuation impact analysis, but the operational momentum could support future sales growth and help justify R&D spend. Overall impact is positive, though quantification awaits further financial disclosure.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

false 0001676163 0001676163 2025-07-15 2025-07-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of report (Date of earliest event reported): July 15, 2025

SS INNOVATIONS INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

Florida		001-42615		47-3478854
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

05, 3rd Floor, iLabs Info Technology Centre Udyog Vihar, Phase III, Gurugram, Haryana, India		122016
Address of Principal Executive Office (Street and Number)		(Zip Code)

Registrant’s telephone number, including area code: +91 73375 53469

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each Class		Trading Symbol		Name of each exchange on which registered
Common Stock		SSII		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

As used in this Current Report on Form 8-K (this “Current Report”), the terms “SSi,” “the Company,” “we,” “us” and “our” refer to SS Innovations International, Inc. and its subsidiaries.

Item 8.01 Other Events.

On July 15, 2025, SSi issued a press release announcing that the Company has installed more than 100 SSi Mantra surgical robotic systems in India and six other countries and that to date, more than 5,000 surgical procedures have been successfully performed utilizing the SSi Mantra, including 240 cardiac surgeries and 32 telesurgeries.

A copy of the press release is included as Exhibit 99.1 to this Report.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
99.1		Press Release, dated July 15, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: July 15, 2025	SS INNOVATIONS INTERNATIONAL, INC.
	By:	/s/ Sudhir Srivastava
		Sudhir Srivastava, M.D.
		Chairman and Chief Executive Officer

2

FAQ

What milestone did SSII announce in its July 15 2025 Form 8-K?

The company reported installing over 100 SSi Mantra surgical robotic systems worldwide.

How many surgical procedures have been performed with the Mantra system?

More than 5,000 procedures have been completed to date.

In how many countries is the Mantra system currently installed?

Installations span India and six other countries, totaling seven nations.

Does the filing include any financial results or guidance?

No. The 8-K is limited to an operational update; no financial data were disclosed.

What exhibit accompanies the 8-K filing?

Exhibit 99.1 contains the press release dated July 15 2025 detailing the milestone.

What is the trading symbol and exchange for SS Innovations International?

The company trades as SSII on The Nasdaq Stock Market LLC.